位置:首页 > 蛋白库 > KCNK2_RAT
KCNK2_RAT
ID   KCNK2_RAT               Reviewed;         426 AA.
AC   Q920B6; A3QR52; Q3MMY3; Q5DNW4; Q5DNW5;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   03-AUG-2022, entry version 130.
DE   RecName: Full=Potassium channel subfamily K member 2 {ECO:0000250|UniProtKB:O95069};
DE   AltName: Full=Outward rectifying potassium channel protein TREK-1 {ECO:0000250|UniProtKB:O95069};
DE   AltName: Full=Stretch-activated potassium channel TREK-1 {ECO:0000303|PubMed:16248991};
DE   AltName: Full=TREK-1 K(+) channel subunit {ECO:0000250|UniProtKB:O95069};
DE   AltName: Full=Two pore domain potassium channel TREK-1 {ECO:0000303|PubMed:24196565};
DE   AltName: Full=Two pore potassium channel TPKC1 {ECO:0000250|UniProtKB:O95069};
GN   Name=Kcnk2 {ECO:0000312|EMBL:AAU06141.1,
GN   ECO:0000312|Ensembl:ENSRNOP00000003684, ECO:0000312|RGD:621448};
GN   Synonyms=Trek {ECO:0000312|EMBL:ABD64605.1};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAL01159.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Brain {ECO:0000312|EMBL:AAL01159.1};
RX   PubMed=11319556; DOI=10.1038/87434;
RA   Bockenhauer D., Zilberberg N., Goldstein S.A.;
RT   "KCNK2: reversible conversion of a hippocampal potassium leak into a
RT   voltage-dependent channel.";
RL   Nat. Neurosci. 4:486-491(2001).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAL95708.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar {ECO:0000312|EMBL:AAL95708.1};
RX   PubMed=11897838; DOI=10.1113/jphysiol.2001.013432;
RA   Gu W., Schlichthorl G., Hirsch J.R., Engels H., Karschin C., Karschin A.,
RA   Derst C., Steinlein O.K., Daut J.;
RT   "Expression pattern and functional characteristics of two novel splice
RT   variants of the two-pore-domain potassium channel TREK-2.";
RL   J. Physiol. (Lond.) 539:657-668(2002).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAU25945.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, AND ACTIVATION.
RX   PubMed=16248991; DOI=10.1016/j.cardiores.2005.08.018;
RA   Tao Li X., Dyachenko V., Zuzarte M., Putzke C., Preisig-Muller R.,
RA   Isenberg G., Daut J.;
RT   "The stretch-activated potassium channel TREK-1 in rat cardiac ventricular
RT   muscle.";
RL   Cardiovasc. Res. 69:86-97(2006).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:ABD64605.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3; 4 AND 5), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND DOMAIN.
RX   PubMed=24196565; DOI=10.1007/s00424-013-1384-z;
RA   Rinne S., Renigunta V., Schlichthorl G., Zuzarte M., Bittner S.,
RA   Meuth S.G., Decher N., Daut J., Preisig-Muller R.;
RT   "A splice variant of the two-pore domain potassium channel TREK-1 with only
RT   one pore domain reduces the surface expression of full-length TREK-1
RT   channels.";
RL   Pflugers Arch. 466:1559-1570(2014).
RN   [5] {ECO:0000305, ECO:0000312|EMBL:AAU06141.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Wistar {ECO:0000312|EMBL:AAU06141.1};
RA   Li Z.B., Wang X.L.;
RT   "Possible role of TREK-1 in temperature regulation.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000312|Ensembl:ENSRNOP00000003684}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway {ECO:0000312|Ensembl:ENSRNOP00000003684};
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [7] {ECO:0000305, ECO:0000312|EMBL:AAU06141.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Ion channel that contributes to passive transmembrane
CC       potassium transport. Reversibly converts between a voltage-insensitive
CC       potassium leak channel and a voltage-dependent outward rectifying
CC       potassium channel in a phosphorylation-dependent manner
CC       (PubMed:11319556). In astrocytes, forms mostly heterodimeric potassium
CC       channels with KCNK1, with only a minor proportion of functional
CC       channels containing homodimeric KCNK2. In astrocytes, the heterodimer
CC       formed by KCNK1 and KCNK2 is required for rapid glutamate release in
CC       response to activation of G-protein coupled receptors, such as F2R and
CC       CNR1 (By similarity). {ECO:0000250|UniProtKB:P97438,
CC       ECO:0000269|PubMed:11319556}.
CC   -!- FUNCTION: [Isoform 5]: Does not display channel activity but reduces
CC       the channel activity of isoform 1, isoform 2 and isoform 4 and reduces
CC       cell surface expression of isoform 2. {ECO:0000269|PubMed:24196565}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked (By similarity). Heterodimer with
CC       KCNK1; disulfide-linked (By similarity). Interacts with BVES; the
CC       interaction enhances KCNK2 surface expression and is inhibited by cAMP
CC       (By similarity). {ECO:0000250|UniProtKB:O95069,
CC       ECO:0000250|UniProtKB:P97438}.
CC   -!- INTERACTION:
CC       Q920B6; P50150: GNG4; Xeno; NbExp=3; IntAct=EBI-6530063, EBI-6395970;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane
CC       {ECO:0000269|PubMed:24196565}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:24196565}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cell membrane
CC       {ECO:0000269|PubMed:24196565}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:24196565}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 5]: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:24196565}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:24196565}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1 {ECO:0000269|PubMed:11319556, ECO:0000269|PubMed:11897838};
CC       Synonyms=TREK-1b {ECO:0000303|PubMed:24196565};
CC         IsoId=Q920B6-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:16248991}; Synonyms=TREK-1a
CC       {ECO:0000303|PubMed:24196565};
CC         IsoId=Q920B6-2; Sequence=VSP_053954;
CC       Name=3 {ECO:0000269|PubMed:24196565}; Synonyms=TREK-1c
CC       {ECO:0000303|PubMed:24196565};
CC         IsoId=Q920B6-3; Sequence=VSP_053952;
CC       Name=4 {ECO:0000269|PubMed:24196565}; Synonyms=TREK-1d
CC       {ECO:0000303|PubMed:24196565};
CC         IsoId=Q920B6-4; Sequence=VSP_053953;
CC       Name=5 {ECO:0000269|PubMed:24196565}; Synonyms=TREK-1e
CC       {ECO:0000303|PubMed:24196565};
CC         IsoId=Q920B6-5; Sequence=VSP_053954, VSP_053955, VSP_053956;
CC   -!- TISSUE SPECIFICITY: Expressed in cardiomyocytes (at protein level).
CC       Expressed in various brain regions including the lateral olfactory
CC       tract, piriform cortex of the forebrain, paraventricular and
CC       anteromedial thalamic nuclei, brainstem, caudate putamen, nucleus
CC       accumbens, neocortex and interpeduncular nucleus. Isoform 5 is
CC       expressed in brain and kidney. {ECO:0000269|PubMed:11897838,
CC       ECO:0000269|PubMed:16248991, ECO:0000269|PubMed:24196565}.
CC   -!- DOMAIN: The C-terminal region of isoform 5 mediates its intracellular
CC       retention. {ECO:0000269|PubMed:24196565}.
CC   -!- PTM: Phosphorylation at Ser-348 controls the reversible conversion from
CC       a leak channel to a voltage-dependent channel.
CC       {ECO:0000250|UniProtKB:O95069}.
CC   -!- MISCELLANEOUS: Activated by arachadonic acid, mechanical stretching and
CC       intracellular acidification. {ECO:0000269|PubMed:16248991}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000255}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF325671; AAL01159.1; -; mRNA.
DR   EMBL; AF385402; AAL95708.1; -; mRNA.
DR   EMBL; AY727922; AAU25945.1; -; mRNA.
DR   EMBL; AY555072; AAT64134.1; -; mRNA.
DR   EMBL; AY555073; AAT64135.1; -; mRNA.
DR   EMBL; DQ403851; ABD64605.1; -; mRNA.
DR   EMBL; AY695826; AAU06141.1; -; mRNA.
DR   EMBL; AABR06076806; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06076807; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06076808; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06076809; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473985; EDL94961.1; -; Genomic_DNA.
DR   EMBL; CH473985; EDL94962.1; -; Genomic_DNA.
DR   RefSeq; NP_742038.2; NM_172041.2.
DR   RefSeq; NP_742039.1; NM_172042.1. [Q920B6-1]
DR   RefSeq; XP_006250495.1; XM_006250433.3. [Q920B6-4]
DR   RefSeq; XP_006250496.1; XM_006250434.3. [Q920B6-2]
DR   AlphaFoldDB; Q920B6; -.
DR   SMR; Q920B6; -.
DR   IntAct; Q920B6; 9.
DR   STRING; 10116.ENSRNOP00000003684; -.
DR   BindingDB; Q920B6; -.
DR   ChEMBL; CHEMBL3817718; -.
DR   GlyGen; Q920B6; 2 sites.
DR   PaxDb; Q920B6; -.
DR   Ensembl; ENSRNOT00000003684; ENSRNOP00000003684; ENSRNOG00000002653. [Q920B6-1]
DR   Ensembl; ENSRNOT00000077282; ENSRNOP00000068842; ENSRNOG00000002653. [Q920B6-3]
DR   Ensembl; ENSRNOT00000103519; ENSRNOP00000077148; ENSRNOG00000002653. [Q920B6-4]
DR   Ensembl; ENSRNOT00000107139; ENSRNOP00000087071; ENSRNOG00000002653. [Q920B6-2]
DR   GeneID; 170899; -.
DR   KEGG; rno:170899; -.
DR   UCSC; RGD:621448; rat. [Q920B6-1]
DR   CTD; 3776; -.
DR   RGD; 621448; Kcnk2.
DR   eggNOG; KOG1418; Eukaryota.
DR   GeneTree; ENSGT00940000156560; -.
DR   HOGENOM; CLU_022504_10_0_1; -.
DR   InParanoid; Q920B6; -.
DR   OMA; TSQISHW; -.
DR   OrthoDB; 616474at2759; -.
DR   PhylomeDB; Q920B6; -.
DR   TreeFam; TF313947; -.
DR   Reactome; R-RNO-1299503; TWIK related potassium channel (TREK).
DR   Reactome; R-RNO-5576886; Phase 4 - resting membrane potential.
DR   PRO; PR:Q920B6; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Proteomes; UP000234681; Chromosome 13.
DR   Bgee; ENSRNOG00000002653; Expressed in frontal cortex and 15 other tissues.
DR   Genevisible; Q920B6; RN.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0097449; C:astrocyte projection; IDA:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0044305; C:calyx of Held; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; ISO:RGD.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0019870; F:potassium channel inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IDA:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; ISO:RGD.
DR   GO; GO:0003231; P:cardiac ventricle development; IEP:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0090102; P:cochlea development; IEP:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007613; P:memory; IEP:RGD.
DR   GO; GO:0060044; P:negative regulation of cardiac muscle cell proliferation; IMP:RGD.
DR   GO; GO:2000279; P:negative regulation of DNA biosynthetic process; IMP:RGD.
DR   GO; GO:0010942; P:positive regulation of cell death; IMP:RGD.
DR   GO; GO:1900039; P:positive regulation of cellular response to hypoxia; IMP:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; ISO:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0048678; P:response to axon injury; IEP:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003976; 2pore_dom_K_chnl_TREK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   PANTHER; PTHR11003; PTHR11003; 1.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01499; TREKCHANNEL.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Disulfide bond; Endoplasmic reticulum;
KW   Glycoprotein; Ion channel; Ion transport; Membrane; Phosphoprotein;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..426
FT                   /note="Potassium channel subfamily K member 2"
FT                   /id="PRO_0000426718"
FT   TOPO_DOM        1..61
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        62..82
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        144..170
FT                   /note="Pore-forming; Name=Pore-forming 1"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        172..192
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        193..222
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        223..243
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        253..283
FT                   /note="Pore-forming; Name=Pore-forming 2"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        288..308
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        309..426
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          354..426
FT                   /note="Required for basal channel activity"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   REGION          378..426
FT                   /note="Essential for chloroform and halothane sensitivity"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   MOD_RES         348
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:O95069"
FT   CARBOHYD        110
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        134
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        108
FT                   /note="Interchain"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   VAR_SEQ         1..16
FT                   /note="MLASASRERPGYTAGV -> MMNPRAKRSVYL (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:24196565"
FT                   /id="VSP_053952"
FT   VAR_SEQ         1..15
FT                   /note="MLASASRERPGYTAG -> MGA (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:24196565"
FT                   /id="VSP_053953"
FT   VAR_SEQ         2..16
FT                   /note="Missing (in isoform 2 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:16248991,
FT                   ECO:0000303|PubMed:24196565"
FT                   /id="VSP_053954"
FT   VAR_SEQ         213..241
FT                   /note="KWNVSQTKIRIISTIIFILFGCVLFVALP -> VGRTLNIWTSTSSSCGSGS
FT                   SLGWPTLRLF (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:24196565"
FT                   /id="VSP_053955"
FT   VAR_SEQ         242..426
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:24196565"
FT                   /id="VSP_053956"
FT   CONFLICT        416
FT                   /note="A -> R (in Ref. 4; ABD64605)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   426 AA;  46912 MW;  CACDA05BBE95FDBC CRC64;
     MLASASRERP GYTAGVAAPD LLDPKSAAQN SKPRLSFSAK PTVLASRVES DSAINVMKWK
     TVSTIFLVVV LYLIIGATVF KALEQPQEIS QRTTIVIQKQ NFIAQHACVN STELDELIQQ
     IVTAINAGII PLGNNSNQVS HWDLGSSFFF AGTVITTIGF GNISPRTEGG KIFCIIYALL
     GIPLFGFLLA GVGDQLGTIF GKGIAKVEDT FIKWNVSQTK IRIISTIIFI LFGCVLFVAL
     PAVIFKHIEG WSALDAIYFV VITLTTIGFG DYVAGGSDIE YLDFYKPVVW FWILVGLAYF
     AAVLSMIGDW LRVISKKTKE EVGEFRAHAA EWTANVTAEF KETRRRLSVE IYDKFQRATS
     VKRKLSAELA GNHNQELTPC RRTLSVNHLT SEREVLPPLL KAESIYLNGL TPHCAAEDIA
     VIENMK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025